Calcium signaling dysfunction in schizophrenia: a unifying approach
暂无分享,去创建一个
[1] D. Weinberger,et al. Dopamine, the prefrontal cortex and schizophrenia , 1997, Journal of psychopharmacology.
[2] C. Cepeda,et al. Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum , 1998, Developmental Neuroscience.
[3] J. Smythies. Oxidative reactions and schizophrenia: A review-discussion , 1997, Schizophrenia Research.
[4] J. Trojanowski,et al. Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. , 2002, Archives of general psychiatry.
[5] P. Hof,et al. targeted disruption of the dopamine D2 and D3 receptor genes leads to different alterations in the expression of striatal Calbindin-D28k , 2000, Neuroscience.
[6] A. Baines,et al. Ca2+-dependent interaction with calmodulin is conserved in the synapsin family: identification of a high-affinity site. , 1997, Biochemistry.
[7] H. Stefánsson,et al. Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.
[8] G. Dayanithi,et al. Ca2+‐regulated, neurosecretory granule channel involved in release from neurohypophysial terminals , 2002, The Journal of physiology.
[9] R. Mrak,et al. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. , 1996, Molecular and chemical neuropathology.
[10] M. Laruelle. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. , 1998, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[11] D. Jeste,et al. Hippocampal pathologic findings in schizophrenia. A morphometric study. , 1989, Archives of general psychiatry.
[12] M. Webster,et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia , 2001, Brain Research Bulletin.
[13] Dorit Ben-Shachar,et al. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine , 2002, Journal of neurochemistry.
[14] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[15] M. Lidow,et al. Differential expression of D1 and D5 dopamine receptors in the fetal primate cerebral wall. , 1997, Cerebral cortex.
[16] I. Batty,et al. Muscarinic Receptors Mediate Phospholipase C-dependent Activation of Protein Kinase B via Ca2+, ErbB3, and Phosphoinositide 3-Kinase in 1321N1 Astrocytoma Cells* , 2002, The Journal of Biological Chemistry.
[17] Hui Zhang,et al. Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme. , 2002, Biochimica et biophysica acta.
[18] A. Pardee,et al. Meeting report; “Molecular neurobiological mechanisms in schizophrenia: seeking a synthesis,” April 11–14, 1999 , 2000, Biological Psychiatry.
[19] Angus C Nairn,et al. The DARPP-32/protein phosphatase-1 cascade: a model for signal integration 1 Published on the World Wide Web on 22 January 1998. 1 , 1998, Brain Research Reviews.
[20] Tsuyoshi Miyaoka,et al. Increased expression of Wnt-1 in schizophrenic brains , 1999, Schizophrenia Research.
[21] S. Muallem,et al. G protein-dependent Ca2+ signaling complexes in polarized cells. , 1999, Cell calcium.
[22] W H Wong,et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] Deborah A Yurgelun-Todd,et al. Differences in cerebellar blood volume in schizophrenia and bipolar disorder , 1999, Schizophrenia Research.
[24] P. Goldman-Rakic,et al. Long-Lasting Psychotomimetic Consequences of Repeated Low-Dose Amphetamine Exposure in Rhesus Monkeys , 1999, Neuropsychopharmacology.
[25] E C Toescu,et al. Apoptosis and cell death in neuronal cells: where does Ca2+ fit in? , 1998, Cell calcium.
[26] L. Berrino,et al. Effects of docosahexaenoic acid on calcium pathway in adult rat cardiomyocytes. , 2002, Life sciences.
[27] N. Andreasen,et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients , 1997, The Lancet.
[28] F. Sharp,et al. Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels , 1994, Neuroscience.
[29] K. Blennow,et al. Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia , 1999, Biological Psychiatry.
[30] Pat Levitt,et al. Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.
[31] S. Fatemi,et al. Altered levels of Reelin and its isoforms in schizophrenia and mood disorders , 2001, Neuroreport.
[32] O. Shirakawa,et al. Isotype-Specific G Protein Abnormalities in the Left Superior Temporal Cortex and Limbic Structures of Patients with Chronic Schizophrenia , 1998, Biological Psychiatry.
[33] H. Lal,et al. Oxidative stress and role of antioxidant and ω-3 essential fatty acid supplementation in schizophrenia , 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[34] P. Greengard,et al. Synapsin I, an actin-binding protein regulating synaptic vesicle traffic in the nerve terminal. , 1994, Advances in second messenger and phosphoprotein research.
[35] A. Guidotti,et al. Dendritic Spine Hypoplasticity and Downregulation of Reelin and GABAergic Tone in Schizophrenia Vulnerability , 2001, Neurobiology of Disease.
[36] G. Ramakers,et al. N-methyl-d-aspartate-induced long-term depression is associated with a decrease in postsynaptic protein kinase C substrate phosphorylation in rat hippocampal slices , 2002, Neuroscience Letters.
[37] K. Davis,et al. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. , 1997, Archives of general psychiatry.
[38] B. Rudy,et al. FGF-2 potentiates Ca(2+)-dependent inactivation of NMDA receptor currents in hippocampal neurons. , 1999, Journal of neurophysiology.
[39] P G Nelson,et al. Mechanisms involved in activity-dependent synapse formation in mammalian central nervous system cell cultures. , 1990, Journal of neurobiology.
[40] D. Horrobin. Schizophrenia as a membrane lipid disorder which is expressed throughout the body. , 1996, Prostaglandins, leukotrienes, and essential fatty acids.
[41] F. Benes,et al. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives , 1998, Biological Psychiatry.
[42] F. Strumwasser,et al. Antipsychotic drugs block IP3-dependent Ca2+-release from rat brain microsomes , 1996, Biological Psychiatry.
[43] E. Yoon,et al. Thrombin Receptors Activate Go Proteins in Endothelial Cells to Regulate Intracellular Calcium and Cell Shape Changes* , 2002, The Journal of Biological Chemistry.
[44] T. Crow,et al. G proteins (Gi, Go) in the medial temporal lobe in schizophrenia: preliminary report of a neurochemical correlate of structural change , 2005, Journal of Neural Transmission / General Section JNT.
[45] D. Weinberger,et al. Prefrontal function in schizophrenia: confounds and controversies. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[46] A. K. Lee,et al. Dopamine (D2) receptor regulation of intracellular calcium and membrane capacitance changes in rat melanotrophs. , 1996, The Journal of physiology.
[47] R. Hoffman,et al. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. , 2000, Archives of general psychiatry.
[48] J. Olney,et al. Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.
[49] Tyrone D. Cannon,et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. , 1994, Archives of general psychiatry.
[50] Paul J. Harrison. The neuropathology of schizophrenia , 2008 .
[51] D. Gerendasy,et al. Homeostatic tuning of Ca2+ signal transduction by members of the calpacitin protein family , 1999, Journal of neuroscience research.
[52] P. Greengard,et al. Inhibition of Mitochondrial Complex II Induces a Long-Term Potentiation of NMDA-Mediated Synaptic Excitation in the Striatum Requiring Endogenous Dopamine , 2001, The Journal of Neuroscience.
[53] J. Cadet,et al. Free radical mechanisms in schizophrenia and tardive dyskinesia , 1994, Neuroscience & Biobehavioral Reviews.
[54] B. Bunney,et al. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. , 1989, The Journal of pharmacology and experimental therapeutics.
[55] F. Benes,et al. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. , 1991, Archives of general psychiatry.
[56] Paul J. Harrison,et al. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia , 1998, Neuroscience.
[57] F. Benes,et al. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex , 1995, Synapse.
[58] J. Palermo-neto. Dopaminergic systems. Dopamine receptors. , 1997, The Psychiatric clinics of North America.
[59] M. Lidow. Neurotransmitter Receptors in Actions of Antipsychotic Medications , 2000 .
[60] J. Bargas,et al. D2 Dopamine Receptors in Striatal Medium Spiny Neurons Reduce L-Type Ca2+ Currents and Excitability via a Novel PLCβ1–IP3–Calcineurin-Signaling Cascade , 2000, The Journal of Neuroscience.
[61] R. Shelton,et al. A negative, double-blind, placebo-controlled, clinical trial of verapamil in chronic schizophrenia , 1986, Biological Psychiatry.
[62] Aryeh Routtenberg,et al. GAP-43: an intrinsic determinant of neuronal development and plasticity , 1997, Trends in Neurosciences.
[63] J. Kornhuber,et al. Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients , 1994, Biological Psychiatry.
[64] P. Cohen,et al. Mitogen-activated protein kinase kinase 7 is activated during low potassium-induced apoptosis in rat cerebellar granule neurons , 2002, Neuroscience Letters.
[65] P. Goldman-Rakic,et al. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[66] J H Skene,et al. GAP-43 as a 'calmodulin sponge' and some implications for calcium signalling in axon terminals. , 1990, Neuroscience research. Supplement : the official journal of the Japan Neuroscience Society.
[67] C. Beasley,et al. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity , 2001, Brain Research Bulletin.
[68] J. Newcomer,et al. NMDA receptor hypofunction model of schizophrenia. , 1999, Journal of psychiatric research.
[69] F. Middleton,et al. Gene Expression Profiling with DNA Microarrays: Advancing Our Understanding of Psychiatric Disorders , 2002, Neurochemical Research.
[70] G. Johnson,et al. Transient Increases in Intracellular Calcium Result in Prolonged Site-selective Increases in Tau Phosphorylation through a Glycogen Synthase Kinase 3β-dependent Pathway* , 1999, The Journal of Biological Chemistry.
[71] S. Chan,et al. Human brain contents of calcium, copper, magnesium, and zinc in some neurological pathologies. , 1975, Clinica chimica acta; international journal of clinical chemistry.
[72] W. Leonhardt,et al. Antioxidative action of the novel calcium channel antagonist mibefradil on low-density lipoproteins , 1998, European Journal of Clinical Pharmacology.
[73] P. Goldman-Rakic. Working memory dysfunction in schizophrenia. , 1994, The Journal of neuropsychiatry and clinical neurosciences.
[74] C. Bramham,et al. Modulation of neuronal calcium signaling by neurotrophic factors , 2002, International Journal of Developmental Neuroscience.
[75] F. Di Virgilio,et al. A role for calcium in Bcl-2 action? , 2002, Biochimie.
[76] D. Souza,et al. Increased serum S100B protein in schizophrenia: a study in medication-free patients. , 2001, Journal of psychiatric research.
[77] R. Segal,et al. Sustained Signaling by Phospholipase C-γ Mediates Nerve Growth Factor-Triggered Gene Expression , 2001, Molecular and Cellular Biology.
[78] J John Mann,et al. The GABAergic system in schizophrenia. , 2002, The international journal of neuropsychopharmacology.
[79] R. D. Schwartz,et al. Bidirectional Modulation of GABA‐Gated Chloride Channels by Divalent Cations: Inhibition by Ca2+ and Enhancement by Mg2+ , 1994, Journal of neurochemistry.
[80] M. Mattson,et al. NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults , 1994, Brain Research.
[81] P. Seeman,et al. Schizophrenia: elevated mRNA for calcium-calmodulin-dependent protein kinase IIbeta in frontal cortex. , 2000, Brain research. Molecular brain research.
[82] S. Kish,et al. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia , 1999, Brain Research.
[83] N. Perrone-Bizzozero,et al. Posttranscriptional regulation of GAP-43 gene expression in PC12 cells through protein kinase C-dependent stabilization of the mRNA , 1993, The Journal of cell biology.
[84] E. G. Jones,et al. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. , 1996, Archives of general psychiatry.
[85] K. Sato,et al. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo. , 1992, Prostaglandins, leukotrienes, and essential fatty acids.
[86] G. Bellomo,et al. Oxidative stress injury studied in isolated intact cells. , 1987, Molecular toxicology.
[87] G. Westbrook,et al. Interactions of Calmodulin and α-Actinin with the NR1 Subunit Modulate Ca2+-Dependent Inactivation of NMDA Receptors , 1999, The Journal of Neuroscience.
[88] Robert Zöchling,et al. Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses , 2001, Schizophrenia Research.
[89] M. Isokawa. Modulation of GABAA receptor-mediated inhibition by postsynaptic calcium in epileptic hippocampal neurons , 1998, Brain Research.
[90] H. Möller,et al. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia , 2001, Schizophrenia Research.
[91] P. Goldman-Rakic,et al. Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[92] Jun Wang,et al. Acceleration of trophoblast differentiation by heparin-binding EGF-like growth factor is dependent on the stage-specific activation of calcium influx by ErbB receptors in developing mouse blastocysts. , 2000, Development.
[93] C. Bruehl,et al. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[94] Gary Fiskum,et al. Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax , 2002, Journal of neurochemistry.
[95] W. Weglicki,et al. Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide. , 2002, Pharmacological research.
[96] N. Popov,et al. Influence of dopamine receptor agonists and antagonists on calmodulin translocation in different brain regions. , 1989, European journal of pharmacology.
[97] J. Benjamins,et al. Increased intracellular calcium alters myelin gene expression in the N20.1 oligodendroglial cell line , 1999, Journal of neuroscience research.
[98] I. Gottesman,et al. The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia , 2002, BMC psychiatry.
[99] H. Vaudry,et al. Effect of dopamine on adenylate cyclase activity, polyphosphoinositide metabolism and cytosolic calcium concentrations in frog pituitary melanotrophs. , 1993, The Journal of endocrinology.
[100] A. Tort,et al. Decreased S100-beta protein in schizophrenia: preliminary evidence , 2000, Schizophrenia Research.
[101] S. Hirsch,et al. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. , 1995, Biochemical and biophysical research communications.
[102] Mark P. Mattson,et al. Calcium as sculptor and destroyer of neural circuitry , 1992, Experimental Gerontology.
[103] D. Weinberger,et al. The effect of apomorphine on regional cerebral blood flow in schizophrenia. , 1989, The Journal of neuropsychiatry and clinical neurosciences.
[104] Paul J. Harrison,et al. Synaptophysin gene expression in schizophrenia , 2000, British Journal of Psychiatry.
[105] Katsuhiko Mikoshiba,et al. The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos , 2002, Nature.
[106] C. Heizmann,et al. S100 proteins: structure, functions and pathology. , 2002, Frontiers in bioscience : a journal and virtual library.
[107] E. Warburton,et al. Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition , 1996, Behavioural pharmacology.
[108] J. Satrústegui,et al. Effects of chronic nimodipine on working memory of old rats in relation to defects in synaptosomal calcium homeostasis. , 1998, European journal of pharmacology.
[109] A. Yarlagadda. Role of calcium regulation in pathophysiology model of schizophrenia and possible interventions. , 2002, Medical hypotheses.
[110] C. Bergson,et al. D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons. , 2002, Journal of neurophysiology.
[111] Daniel R Weinberger,et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study , 2002, Schizophrenia Research.
[112] Fabio Benfenati,et al. Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I , 1992, Nature.
[113] P. Gonçalves,et al. Ca2+ Sensitivity of Synaptic Vesicle Dopamine, γ-Aminobutyric Acid, and Glutamate Transport Systems , 2004, Neurochemical Research.
[114] Shaoyu Zhou,et al. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats. , 2001, Toxicology and applied pharmacology.
[115] J. Lehmann,et al. Functional Screening of G Protein—Coupled Receptors by Measuring Intracellular Calcium with a Fluorescence Microplate Reader , 2002, Journal of biomolecular screening.
[116] G. Rosenbaum,et al. Comparison of sernyl with other drugs: simulation of schizophrenic performance with sernyl, LSD-25, and amobarbital (amytal) sodium; I. Attention, motor function, and proprioception. , 1959, A.M.A. archives of general psychiatry.
[117] F. Benes,et al. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. , 1986, Archives of general psychiatry.
[118] B. Bogerts,et al. Cell loss in the hippocampus of schizophrenics , 2004, European archives of psychiatry and neurological sciences.
[119] P. Goldman-Rakic,et al. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[120] D. Copolov,et al. Biological markers and schizophrenia. , 2000, The Australian and New Zealand journal of psychiatry.
[121] M. Berk,et al. The platelet as a peripheral marker in psychiatric illness , 2001, Human psychopharmacology.
[122] A. Schousboe,et al. Role of GABAB receptors in intracellular Ca2+ homeostasis and possible interaction between GABAA and GABAB receptors in regulation of transmitter release in cerebellar granule neurons , 1994, Journal of neuroscience research.
[123] Helen L. Yin,et al. Gelsolin, a Multifunctional Actin Regulatory Protein* , 1999, The Journal of Biological Chemistry.
[124] J. Coyle,et al. Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.
[125] Yogesh K. Dwivedi,et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[126] O. Shirakawa,et al. Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia , 1999, Biological Psychiatry.
[127] M. Valdeolmillos,et al. Receptor-activated calcium signals in tangentially migrating cortical cells. , 2002, Cerebral cortex.
[128] L. Pallanck,et al. NSF Function in Neurotransmitter Release Involves Rearrangement of the SNARE Complex Downstream of Synaptic Vesicle Docking , 1998, The Journal of Neuroscience.
[129] Douglas W. Jones,et al. The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[130] C. Beasley,et al. Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia , 2001, Neuroscience Letters.
[131] Yu Tian Wang,et al. Dual Regulation of NMDA Receptor Functions by Direct Protein-Protein Interactions with the Dopamine D1 Receptor , 2002, Cell.
[132] W. Fenton,et al. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia , 2000, Biological Psychiatry.
[133] T. Goldberg,et al. Cognitive impairment in schizophrenia is the core of the disorder. , 2000, Critical reviews in neurobiology.
[134] C. Pantelis,et al. Implications of Lipid Biology for the Pathogenesis of Schizophrenia , 2002, The Australian and New Zealand journal of psychiatry.
[135] R. Levenson,et al. D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. , 2002, Molecular pharmacology.
[136] J. Kaplan,et al. CaMKII regulates the density of central glutamatergic synapses in vivo , 1999, Nature.
[137] Jeffrey K. Yao,et al. Oxidative Damage and Schizophrenia , 2001, CNS drugs.
[138] C. Iadecola,et al. Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? , 1993, Trends in Neurosciences.
[139] A. Strunecká,et al. What can the investigation of phosphoinositide signaling system in platelets of schizophrenic patients tell us? , 1999, Prostaglandins, leukotrienes, and essential fatty acids.
[140] G. Krauss. Biochemistry of signal transduction and regulation , 1999 .
[141] C. Guerri,et al. Astrocytes in culture express the full-length Trk-B receptor and respond to brain derived neurotrophic factor by changing intracellular calcium levels: effect of ethanol exposure in rats , 2000, Neuroscience Letters.
[142] W. Honer,et al. Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness , 1999, Neuroscience.
[143] D. Lewis,et al. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.
[144] M. Webster,et al. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium , 2001, Brain Research Bulletin.
[145] M. Wiesmann,et al. Elevated plasma levels of S-100b protein in schizophrenic patients , 1999, Biological Psychiatry.
[146] Ramin Homayouni,et al. Reelin Is a Ligand for Lipoprotein Receptors , 1999, Neuron.
[147] H Y Wang,et al. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. , 1995, Molecular pharmacology.
[148] F. Angelucci,et al. Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders. , 2000, Medical hypotheses.
[149] A. Arnsten,et al. D1 dopamine receptors in the mouse prefrontal cortex: Immunocytochemical and cognitive neuropharmacological analyses , 2003, Synapse.
[150] E. Gundelfinger,et al. Intracellular neuronal calcium sensor proteins: a family of EF-hand calcium-binding proteins in search of a function , 1999, Cell and Tissue Research.
[151] Chau-Chung Wu,et al. Arachidonic acid‐induced H+ and Ca2+ increases in both the cytoplasm and nucleoplasm of rat cerebellar granule cells , 2001, The Journal of physiology.
[152] P. Goldman-Rakic,et al. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. , 2000, Science.
[153] H Nawa,et al. Cytokine and growth factor involvement in schizophrenia—support for the developmental model , 2000, Molecular Psychiatry.
[154] K. Davies,et al. Calcium and oxidative stress: from cell signaling to cell death. , 2002, Molecular immunology.
[155] T. Sawada,et al. Inhibiting neuronal migration by blocking NMDA receptors in the embryonic rat cerebral cortex: a tissue culture study. , 1999, Brain research. Developmental brain research.
[156] P. Goldman-Rakic,et al. The cerebral cortex: a case for a common site of action of antipsychotics. , 1998, Trends in pharmacological sciences.
[157] D. Swanson,et al. Calcium-independent phospholipase A2 and schizophrenia. , 1998, Archives of general psychiatry.
[158] Jeffrey C. Erlich,et al. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. , 1997, Archives of general psychiatry.
[159] V. Tkachuk,et al. Heterotrimeric Gi protein is associated with the inositol 1,4,5-trisphosphate receptor complex and modulates calcium flux. , 1998, Cell calcium.
[160] M. Lidow. General Overview of Contemporary Antipsychotic Medications , 2000 .
[161] R. McCarron,et al. Dopaminergic Receptors Linked to Adenylate Cyclase in Human Cerebromicrovascular Endothelium , 1991, Journal of neurochemistry.
[162] P. Goldman-Rakic,et al. Up-regulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia. , 2003, Archives of general psychiatry.
[163] S. Arnold,et al. Neurodevelopmental abnormalities in schizophrenia: Insights from neuropathology , 1999, Development and Psychopathology.
[164] Anirvan Ghosh,et al. Calcium Regulation of Dendritic Growth via CaM Kinase IV and CREB-Mediated Transcription , 2002, Neuron.
[165] P. Goldman-Rakic,et al. Interaction with Neuronal Calcium Sensor NCS-1 Mediates Desensitization of the D2 Dopamine Receptor , 2002, The Journal of Neuroscience.
[166] J. R. Möller. Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates , 1996, Brain Research.
[167] F. Benes,et al. GABAergic Interneurons: Implications for Understanding Schizophrenia and Bipolar Disorder , 2001, Neuropsychopharmacology.
[168] A Carlsson,et al. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. , 2001, Annual review of pharmacology and toxicology.
[169] N. Brandon,et al. GABAA Receptor Phosphorylation and Functional Modulation in Cortical Neurons by a Protein Kinase C-dependent Pathway* , 2000, The Journal of Biological Chemistry.
[170] S. Cragg,et al. Dopamine receptors--physiological understanding to therapeutic intervention potential. , 1999, Pharmacology & therapeutics.
[171] E. I. Astashkin,et al. A dual effect of arachidonic acid on Ca2+ transport systems in lymphocytes , 1994, FEBS letters.
[172] T. Crow,et al. Reduced concentrations of the α-subunit of GTP-binding protein Go in schizophrenic brain , 2005, Journal of Neural Transmission / General Section JNT.
[173] H. Ahorn,et al. Binding of Calmodulin to the D2-Dopamine Receptor Reduces Receptor Signaling by Arresting the G Protein Activation Switch* , 2000, The Journal of Biological Chemistry.
[174] J. Yesavage,et al. Acute phencyclidine (PCP) intoxication: psychopathology and prognosis. , 1978, The Journal of clinical psychiatry.
[175] F. Goodwin,et al. CSF calcium: clinical correlates in affective illness and schizophrenia. , 1979, Biological psychiatry.
[176] J. Mazière,et al. Could the interaction of neuroleptics with calmodulin be an "explanation" of the psychotropic effects? , 1991, L'Encephale.
[177] J. Kleinman,et al. Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia , 2001, Schizophrenia Research.
[178] C. Casagrande,et al. Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.
[179] Guoqiang Xing,et al. Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression , 2002, Schizophrenia Research.
[180] B. Bogerts,et al. Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia , 2001, Journal of neurocytology.
[181] P. Goldman-Rakic,et al. Modulation of memory fields by dopamine Dl receptors in prefrontal cortex , 1995, Nature.
[182] R. Donato,et al. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. , 2001, The international journal of biochemistry & cell biology.
[183] P. Sastry,et al. Apoptosis and the Nervous System , 2000, Journal of neurochemistry.
[184] K. Blennow,et al. Mitochondrial Function is Differentially Altered in the Basal Ganglia of Chronic Schizophrenics , 1999, Neuropsychopharmacology.
[185] C. Kahn,et al. Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[186] N. Perrone-Bizzozero,et al. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[187] D. Goff,et al. Glutamate in schizophrenia: clinical and research implications , 1997, Schizophrenia Research.
[188] Paul Greengard,et al. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. , 2002, Archives of general psychiatry.
[189] S. Muallem,et al. RGS Proteins Determine Signaling Specificity of Gq-coupled Receptors* , 1999, The Journal of Biological Chemistry.
[190] P. Greengard,et al. A Dopamine/D1 Receptor/Protein Kinase A/Dopamine- and cAMP-Regulated Phosphoprotein (Mr 32 kDa)/Protein Phosphatase-1 Pathway Regulates Dephosphorylation of the NMDA Receptor , 1998, The Journal of Neuroscience.
[191] William Byne,et al. Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex , 2002, Schizophrenia Research.
[192] P. Goldman-Rakic,et al. The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.
[193] C. Tanaka,et al. D2‐dopamine receptor‐mediated inhibition of intracellular Ca2+ mobilization and release of acetylcholine from guinea‐pig neostriatal slices , 1987, British Journal of Pharmacology.
[194] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[195] H. Nawa,et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients , 2002, Psychiatry Research.
[196] A. Meyer-Lindenberg,et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia , 2002, Nature Neuroscience.
[197] A. Martínez-Serrano,et al. Modulation of presynaptic calcium homeostasis by nitric oxide. , 1996, Cell calcium.
[198] Akira Sawa,et al. Schizophrenia: Diverse Approaches to a Complex Disease , 2002, Science.
[199] J. Pierri,et al. Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia , 2002, The Journal of Neuroscience.
[200] J. Glowinski,et al. Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex , 1986, Brain Research Bulletin.
[201] C. Gerfen. The neostriatal mosaic: multiple levels of compartmental organization. , 1992 .
[202] C. Davio,et al. Molecular mechanisms involved in the actions of apotransferrin upon the central nervous system: Role of the cytoskeleton and of second messengers , 2002, Journal of neuroscience research.
[203] B. Dean,et al. Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia , 2005, Journal of Neural Transmission.
[204] J. Lieberman,et al. Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia , 2000, Biological Psychiatry.
[205] B. Bogerts,et al. Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia , 2002, Neuroreport.
[206] G J Barker,et al. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.
[207] N. Perrone-Bizzozero,et al. Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method. , 1995, Molecular and chemical neuropathology.
[208] George Bartzokis,et al. Schizophrenia: Breakdown in the Well-regulated Lifelong Process of Brain Development and Maturation , 2002, Neuropsychopharmacology.
[209] G. Westbrook,et al. Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors , 2002, Neuropharmacology.
[210] T. Taguchi,et al. Basic Fibroblast Growth Factor Evokes a Rapid Glutamate Release through Activation of the MAPK Pathway in Cultured Cortical Neurons* , 2002, The Journal of Biological Chemistry.
[211] R. Moon,et al. The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. , 2000, Trends in genetics : TIG.
[212] M. Segal. Rapid plasticity of dendritic spine: hints to possible functions? , 2001, Progress in Neurobiology.
[213] M. Ishii,et al. Ca2+ Elevation Evoked by Membrane Depolarization Regulates G Protein Cycle via RGS Proteins in the Heart , 2001, Circulation research.
[214] M. Owen,et al. Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology. , 1999, The international journal of neuropsychopharmacology.
[215] E. F. Stanley,et al. G-Protein Types Involved in Calcium Channel Inhibition at a Presynaptic Nerve Terminal , 2000, The Journal of Neuroscience.
[216] M. Gnegy,et al. Enhanced Amphetamine- and K+-Mediated Dopamine Release in Rat Striatum after Repeated Amphetamine: Differential Requirements for Ca2+- and Calmodulin-Dependent Phosphorylation and Synaptic Vesicles , 1999, The Journal of Neuroscience.
[217] N. Spitzer,et al. Regulation of Calcineurin by Growth Cone Calcium Waves Controls Neurite Extension , 2000, The Journal of Neuroscience.
[218] V. Němcová,et al. Phospholipids and calcium alterations in platelets of schizophrenic patients. , 1997, Physiological research.
[219] A. van Ooyen,et al. The role of calcium signaling in early axonal and dendritic morphogenesis of rat cerebral cortex neurons under non-stimulated growth conditions. , 2001, Brain research. Developmental brain research.
[220] G. Reynolds,et al. Neuronal calcium-binding proteins and schizophrenia , 2002, Schizophrenia Research.
[221] M. Gnegy,et al. Repeated haloperidol increases both calmodulin and a calmodulin-binding protein in rat striatum. , 1994, Brain research. Molecular brain research.
[222] E. Friedman,et al. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. , 1990, The Journal of pharmacology and experimental therapeutics.
[223] K. Blennow,et al. Putamen Mitochondrial Energy Metabolism Is Highly Correlated to Emotional and Intellectual Impairment in Schizophrenics , 2000, Neuropsychopharmacology.
[224] Stephan Heckers,et al. Schizophrenia and cognitive function , 2000, Current Opinion in Neurobiology.
[225] B. Orser,et al. A D2 Class Dopamine Receptor Transactivates a Receptor Tyrosine Kinase to Inhibit NMDA Receptor Transmission , 2002, Neuron.
[226] B. Ross,et al. Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia , 1999, Biological Psychiatry.
[227] J. Seamans,et al. Developing a Neuronal Model for the Pathophysiology of Schizophrenia Based on the Nature of Electrophysiological Actions of Dopamine in the Prefrontal Cortex , 1999, Neuropsychopharmacology.
[228] R. Belmaker,et al. GSK-3 and the neurodevelopmental hypothesis of schizophrenia , 2002, European Neuropsychopharmacology.
[229] H. Kaiya. Second messenger imbalance hypothesis of schizophrenia. , 1992 .
[230] J. Kleinman,et al. Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. , 2001, Cerebral cortex.
[231] E G Jones,et al. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[232] K. Blennow,et al. Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia , 2002, Schizophrenia Research.
[233] G. Sobal,et al. Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation. , 2001, Biochemical pharmacology.
[234] Y. Mori,et al. Binding of Gαo N Terminus Is Responsible for the Voltage-resistant Inhibition of α1A (P/Q-type, Cav2.1) Ca2+ Channels* , 2001, The Journal of Biological Chemistry.
[235] B. Weiss,et al. Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications. , 1982, Biochemical pharmacology.
[236] R. Freedman,et al. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics , 1993, Biological Psychiatry.